Published in IEEE Trans Biomed Eng on March 01, 1998
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Mov Disord (2009) 2.00
Essential tremor quantification during activities of daily living. Parkinsonism Relat Disord (2011) 1.18
Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population. BMC Neurol (2005) 1.14
Continuous monitoring of turning in patients with movement disability. Sensors (Basel) (2013) 1.05
Nonlinear analysis of motor activity shows differences between schizophrenia and depression: a study using Fourier analysis and sample entropy. PLoS One (2011) 1.04
Sleep, vigilance, and thermosensitivity. Pflugers Arch (2011) 0.95
Long-term EMG recordings differentiate between parkinsonian and essential tremor. J Neurol (2008) 0.86
Sleep estimates using microelectromechanical systems (MEMS). Sleep (2013) 0.83
Transducer-based evaluation of tremor. Mov Disord (2016) 0.82
Clinicians' Tendencies to Under-Rate Parkinsonian Tremors in the Less Affected Hand. PLoS One (2015) 0.75
Wearable IMU for Shoulder Injury Prevention in Overhead Sports. Sensors (Basel) (2016) 0.75
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiol Aging (2001) 3.06
A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med (2000) 2.92
A sex difference in the human brain and its relation to transsexuality. Nature (1995) 2.64
Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology (2006) 2.32
Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry (1996) 2.17
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev (2007) 1.94
The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res (1985) 1.87
Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology (2008) 1.80
Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry (2008) 1.78
Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int (1999) 1.77
Oxytocin deficiency at delivery with epidural analgesia. Br J Obstet Gynaecol (1983) 1.77
Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry (1990) 1.74
Blepharospasm in association with a lower pontine lesion. Neurology (1996) 1.71
Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry (1997) 1.71
Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet (1999) 1.67
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci (1985) 1.67
Fetal and maternal diurnal rhythms during the third trimester of normal pregnancy: outcomes of computerized analysis of continuous twenty-four-hour fetal heart rate recordings. Am J Obstet Gynecol (1998) 1.60
Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab (2000) 1.60
Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology (1994) 1.60
Acute dysautonomia associated with Hodgkin's disease. J Neurol Neurosurg Psychiatry (1986) 1.57
Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry (1996) 1.54
Movement, imaging and neurobehavioral assessment as predictors of cerebral palsy in preterm infants. J Perinatol (2007) 1.52
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 1.51
Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry (1999) 1.49
Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry (1995) 1.47
Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review. Neurology (2002) 1.47
Functional neuronal activity and connectivity within the subthalamic nucleus in Parkinson's disease. Clin Neurophysiol (2012) 1.46
The vasopressinergic innervation of the brain in normal and castrated rats. J Comp Neurol (1985) 1.45
Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J Endocrinol (1975) 1.43
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry (2007) 1.42
Deep brain stimulation in addiction: a review of potential brain targets. Mol Psychiatry (2011) 1.42
Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain (1994) 1.32
Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry (1995) 1.29
Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology (1996) 1.29
Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res (1978) 1.29
Evolution of mild cognitive impairment in Parkinson disease. Neurology (2013) 1.28
The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med (2001) 1.28
A sexually dimorphic nucleus in the human brain. Science (1985) 1.27
Brain banking and the human hypothalamus--factors to match for, pitfalls and potentials. Prog Brain Res (1992) 1.26
Diffusion tensor brain imaging findings at term-equivalent age may predict neurologic abnormalities in low birth weight preterm infants. AJNR Am J Neuroradiol (2003) 1.26
Multicentre European study of thalamic stimulation in essential tremor: a six year follow up. J Neurol Neurosurg Psychiatry (2003) 1.23
Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry (1996) 1.22
Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci (2001) 1.22
The Y-chromosomal genes SRY and ZFY are transcribed in adult human brain. Neurogenetics (1998) 1.21
Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol (2001) 1.19
VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging (1996) 1.18
Apoptosis during sexual differentiation of the bed nucleus of the stria terminalis in the rat brain. J Neurobiol (2000) 1.17
Motor procedural learning in Parkinson's disease. Brain (2007) 1.16
Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol (1990) 1.16
Physical activity and executive functions in the elderly with mild cognitive impairment. Aging Ment Health (2005) 1.13
Senescence, sleep, and circadian rhythms. Ageing Res Rev (2002) 1.13
The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease. Neurology (2007) 1.12
Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res (1981) 1.12
Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophypopseal system. J Neural Transm (1975) 1.11
Thixotropy of levator palpebrae as the cause of lagophthalmos after peripheral facial nerve palsy. J Neurol Neurosurg Psychiatry (2002) 1.11
Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry (2007) 1.11
Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry (2008) 1.11
Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging (1990) 1.10
Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin. Brain (2007) 1.09
Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry (2006) 1.09
The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord (1995) 1.08
Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol (2000) 1.07
Ontogeny of the vasopressinergic neurons of the suprachiasmatic nucleus and their extrahypothalamic projections in the rat brain--presence of a sex difference in the lateral septum. Brain Res (1981) 1.07
Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res (1994) 1.07
Can specificity ever be proved in immunocytochemical staining. J Histochem Cytochem (1977) 1.07
Profuse bleeding from a duodenal diverticulum. Am J Gastroenterol (1994) 1.06
Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain (1995) 1.05
Immuno-electron microscopical demonstration of vasopressin and oxytocin synapses in the limbic system of the rat. Cell Tissue Res (1979) 1.05
Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol (2000) 1.04
Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab (1997) 1.03
Long-term fitness training improves the circadian rest-activity rhythm in healthy elderly males. J Biol Rhythms (1997) 1.03
Vasopressin and the output of the hypothalamic biological clock. J Neuroendocrinol (2010) 1.02
Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab (1999) 1.02
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology (2004) 1.01
The sexually dimorphic nucleus of the preoptic area in the human brain: a comparative morphometric study. J Anat (1989) 1.00
Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease. Synapse (2001) 1.00
One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT. J Nucl Med (1999) 1.00
Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: chronobiological perspectives. Behav Brain Res (1993) 0.99
Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications. Rev Neurosci (2007) 0.99
Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology (2006) 0.99
Motor persistence of orbicularis oculi muscle in eyelid-opening disorders. Neurology (1995) 0.98
DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol (1997) 0.97
Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol (1993) 0.96
Physiological effects of kangaroo care in very small preterm infants. Biol Neonate (1991) 0.96
Microwave-enhanced in situ end-labeling of fragmented DNA: parametric studies in relation to postmortem delay and fixation of rat and human brain. J Histochem Cytochem (1995) 0.96
Neuronal discharge patterns in the occipital cortex of developing rats during active and quiet sleep. Brain Res (1982) 0.95
A direct androgenic involvement in the expression of human corticotropin-releasing hormone. Mol Psychiatry (2006) 0.95